Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Vaginex W Tripelennamine Crm 2% 2 % Cream is a Health Canada–registered human drug (DIN 00584096) held by Julius Schmid Canada Ltd., containing Tripelennamine Hydrochloride. Health Canada lists its status as Cancelled Post Market (status date 07 Aug 1997). Nexara Health has matched 19 registrations of Tripelennamine Hydrochloride across 4 other regulated markets.

Health Canada registration

DIN00584096
Brand nameVaginex W Tripelennamine Crm 2%
Active ingredientTripelennamine Hydrochloride
Strength2 %
Dosage formCream
RouteVaginal
CompanyJulius Schmid Canada Ltd.
StatusCancelled Post Market — 07 Aug 1997
ClassHuman
ATC
AHFS04:04.08
Regulator recordHealth Canada DPD entry · Product monograph

Tripelennamine Hydrochloride registered in other markets

19 registrations of the same molecule in 4 national registries outside Canada (first 13 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
FinlandEtonoPerrigo Sverige AB20 mg/gihopuikkoMyyntilupa myönnettyFimea Perusrekisteri
FinlandVetibenzamin VetNovartis Pharma Stein AG20 mg/mlinjektionesteMyyntilupa peruuntunutFimea Perusrekisteri
NetherlandsAzaron Stick, stift 20 mg/gOmega Pharma Nederland B.V.HuidstiftAlgemene verkoop [conform voorwaarden CBG AV-lijst d.d. 6 september 2007]EU national register
NetherlandsAzaron, crème 20 mg/gOmega Pharma Nederland B.V.CrèmeAlgemene verkoop [conform voorwaarden CBG AV-lijst d.d. 6 september 2007]EU national register
TaiwanIpelennamine HCl Tablets "Jen Sheng"人生製藥股份有限公司錠劑已註銷TFDA
TaiwanTripelennamine Hc1 Tablets "Chi Sheng"濟生化學製藥廠股份有限公司錠劑已註銷TFDA
TaiwanTripelennamine Hc1 Tablets 50mg "Johnson"強生化學製藥廠有限公司錠劑已註銷TFDA
TaiwanTripelennamine HClDolder Ltd.(粉)已註銷TFDA
TaiwanTripelennamine HClInternazionale Farmaceutical S. P. A.(粉)已註銷TFDA
TaiwanTripelennamine HClWander Chemical Ltd.(粉)已註銷TFDA
TaiwanTripelennamine HClArchemia S.p.a.(粉)已註銷TFDA
TaiwanTripelennamine HClInternazionale Farmaceutical S. P. A.(粉)已註銷TFDA
United StatesTripelennamine HydrochlorideKingchem Laboratories Inc.PowderFDA NDC

See every manufacturer of Tripelennamine Hydrochloride worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Vaginex W Tripelennamine Crm 2% (DIN 00584096) marketed in Canada?

No. Health Canada lists DIN 00584096 as Cancelled Post Market as of 07 Aug 1997.

Who holds the Canadian licence for this product?

Julius Schmid Canada Ltd. is the company of record in the Health Canada Drug Product Database.

Is Tripelennamine Hydrochloride registered outside Canada?

Yes — Nexara Health has matched 19 registrations in 4 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 00584096, status date 1997-08-07; national medicine registries: EU national register, FDA NDC, Fimea Perusrekisteri, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 00584096, status date 1997-08-07; national medicine registries: EU national register, FDA NDC, Fimea Perusrekisteri, TFDA.

Health Canada Drug Product Database (DPD), DIN 00584096, status date 1997-08-07; national medicine registries: EU national register, FDA NDC, Fimea Perusrekisteri, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.